ST

Srinivas Tatavarthi

Active Director Designated Partner DIN 10609924
DIN 10609924 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivas Tatavarthi

Data last updated:

Srinivas Tatavarthi is a Designated Partner at Yunan Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10609924
Primary Designation Designated Partner
Industry Pharma
First Appointment 29 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Apr 20242024Active

Board colleagues of Srinivas Tatavarthi

NameDINCompanyDesignation
Sarada Yeddanapudi11222972Yunan Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Yunan Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Srinivas Tatavarthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Tatavarthi

Srinivas Tatavarthi currently holds 1 directorship: Yunan Pharmaceuticals Llp (Designated Partner, since 29 Apr 2024).

Srinivas Tatavarthi was first appointed on 29 Apr 2024 as Designated Partner at Yunan Pharmaceuticals Llp.

The current boards of Srinivas Tatavarthi's companies include Sarada Yeddanapudi (Yunan Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available